Colorado Neurological Research Center, PC

Denver, Colorado 80210

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early